Tumor infiltrating lymphocyte therapy: current understanding and comparison with CAR-T therapy

被引：0

作者：

Shefa, Kamrun N. ^{[1
]}

Shuvo, Pollob A. ^{[2
]}

Emran, Talha B. ^{[1
]}

机构：

[1] Daffodil Int Univ, Fac Allied Hlth Sci, Dept Pharm, Dhaka, Bangladesh

[2] Texas A&M Univ, Dept Pharmaceut Sci, College Stn, TX USA

来源：

关键词：

D O I：

10.1097/IO9.0000000000000189

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

引用

页码：674 / 675

页数：2

共 50 条

[31] Target selection for CAR-T therapy
Wei, Jianshu
Han, Xiao
Bo, Jian
Han, Weidong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
[32] Building safety into CAR-T therapy
Peters, Daniel T.
Savoldo, Barbara
Grover, Natalie S.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
[33] CAR-T Cell Therapy for Lymphoma
Ramos, Carlos A.
Heslop, Helen E.
Brenner, Malcolm K.
ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 165 - 183
[34] CAR-T Cell Therapy and the Neurointensivist
Wijdicks, Eelco F. M.
Rabinstein, Alejandro A.
Lin, Yi
NEUROCRITICAL CARE, 2024, : 691 - 694
[35] Optimizing CAR-T Therapy for Glioblastoma
Oliver Y. Tang
Zev A. Binder
Donald M. O’Rourke
Stephen J. Bagley
Molecular Diagnosis & Therapy, 2023, 27 : 643 - 660
[36] Optimizing CAR-T Therapy for Glioblastoma
Tang, Oliver Y.
Binder, Zev A.
O'Rourke, Donald M.
Bagley, Stephen J.
MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (06) : 643 - 660
[37] Recent Advances in CAR-T Therapy
Ali, Meher Binte
CANCER CONTROL, 2024, 31
[38] Relapses After CAR-T Therapy
Abbasi, Jennifer
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (18): : 1850 - 1850
[39] Target selection for CAR-T therapy
Jianshu Wei
Xiao Han
Jian Bo
Weidong Han
Journal of Hematology & Oncology, 12
[40] Gut microbiome and CAR-T therapy
Abid, Muhammad Bilal
Shah, Nirav N.
Maatman, Theresa C.
Hari, Parameswaran N.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)